Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zepbound
Pharma
Obesity not a winner-takes-all game, Novo CEO says: Reuters
Not agreeing that there can be only one victor among obesity drugmakers, Novo Nordisk’s CEO thinks that investors aren’t seeing the whole picture.
Fraiser Kansteiner
Aug 13, 2026 11:33am
Eli Lilly's Zepbound preferred by physicians: Spherix survey
Aug 7, 2026 11:36am
AbbVie’s Skyrizi leading drug in pharma’s ad spending league
Aug 7, 2026 9:45am
Lilly, Resilience will spend $750M to upgrade Cincinnati site
Jul 30, 2026 8:35am
Novo accuses Lilly of running ‘false and misleading’ GLP-1 ads
Jul 21, 2026 9:18am
Obesity meds, China drive $2T in projected 2032 drug sales: report
Jun 23, 2026 9:00am
